Note 2 - Liquidity (Details Textual) - USD ($) |
1 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Jun. 18, 2019 |
Dec. 31, 2017 |
Nov. 30, 2017 |
Sep. 30, 2019 |
Sep. 30, 2018 |
|
Proceeds from Issuance of Common Stock | $ 6,046,915 | $ 3,000,200 | |||
Underwritten Public Offering [Member] | |||||
Stock Issued During Period, Shares, New Issues | 8,000,000 | ||||
Shares Issued, Price Per Share | $ 0.75 | ||||
Proceeds from Issuance of Common Stock | $ 5,555,000 | ||||
Underwritten Public Offering [Member] | John K. Scott, Jr. [Member] | |||||
Stock Issued During Period, Shares, New Issues | 4,000,000 | ||||
Shares Issued, Price Per Share | $ 0.75 | ||||
Underwritten Public Offering [Member] | Underwriter [Member] | |||||
Stock Issued During Period, Shares, New Issues | 4,000,000 | ||||
Shares Issued, Price Per Share | $ 0.69375 | ||||
CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member] | |||||
Loss Contingency, Damages Awarded, Value, Amount not Taken into Consideration | $ 4,100,000 | $ 4,100,000 | |||
Platinum-Montaur Life Sciences LLC Litigation [Member] | |||||
Loss Contingency, Damages Sought, Value | $ 1,900,000 |
X | ||||||||||
- Definition Represents the amount that was not taken into consideration related to damages awarded. No definition available.
|
X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|